Posted by Michael Wonder on 21 Nov 2025
US pharma ramps up attack on Australia’s ‘discriminatory’ drug pricing
20 November 2025 - The US pharmaceutical industry is increasing pressure on Donald Trump to take action against the PBS, which it says makes Australia one of the most difficult countries in the world to get new medicines approved and funded.
A powerful lobby group that includes Eli Lilly, Pfizer and Johnson & Johnson said Australia’s “unreasonable and discriminatory” drug pricing policies were harming American innovation, jobs and the ability of US drug companies to develop life-saving medicines.
